Paloma Partners’s Medicines Co MDCO Stock Holding History

Paloma Partners’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-123,340	Closed	-$10.5M	–	2402
2019 Q4	$10.5M	Buy	+123,340	New	+$8.23M	0.16%	80
2017 Q4	–	Sell	-17,979	Closed	-$666K	–	2459
2017 Q3	$666K	Buy	+17,979	New	+$663K	0.01%	1383
2016 Q3	–	Sell	-13,447	Closed	-$453K	–	2265
2016 Q2	$453K	Buy	+13,447	New	+$474K	0.01%	1584
2014 Q4	–	Sell	-22,000	Closed	-$491K	–	1462
2014 Q3	$491K	Buy	+22,000	New	+$559K	0.02%	545

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Paloma Partners's MDCO Position: Q1 2020 in Review

Paloma Partners sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 123,340 shares — an estimated $10.5M sold.

Paloma Partners first reported a position in MDCO in Q3 2014 and held it in 4 quarters. The position peaked at $10.5M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Paloma Partners reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Paloma Partners sold 123,340 Medicines Co shares in Q1 2020, an estimated $10.5M.
Paloma Partners first reported a position in Medicines Co in Q3 2014 and held it in 4 quarters.
Paloma Partners's Medicines Co position peaked at $10.5M in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Paloma Partners's 13F filing for Q1 2020, filed 15 May 2020.